This is the first investigation of B. coagulans MTCC 5856 as a single probiotic agent at a dose of two × 109 spores (cfu) per day which demonstrated efficacy and safety in the patients experiencing MDD symptoms with IBS. The every day meals intake of the patients was recorded in the affected person diaries provided to them at Visit 1 (Day 0) If you enjoyed t...